There is significant interest inMNOV by institutional investors. The 4.24% of outstanding shares they control represents a greater percentage of ownership than at any other company in the Biotechnology industry. Additionally, during the quarter ended March 2014, these large investors purchased a net $167.0 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WEALTHFRONT, INC. Bought 190.00 shares of MediciNova Inc